Effects of Clopidogrel with Proton Pump Inhibitors on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus after Bare-Metal Stent

被引：0
|
作者：
Hsieh, Chi-Feng [1 ]
Lu, Pei-Yu [1 ]
Huang, Weng-Foung [1 ]
机构：
[1] Natl Yang Ming Univ, Coll Med, Inst Hlth & Welf Policy, Taipei 112, Taiwan
来源：
DRUG SAFETY | 2012年 / 35卷 / 10期
关键词：
ADVERSE OUTCOMES; CONCOMITANT USE; RISK;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：917 / 918
页数：2
相关论文
共 50 条
  • [1] Effects of Clopidogrel and Proton Pump Inhibitors on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus after Bare Metal Stent Implantation: A Nationwide Cohort Study
    Lee, Chun-Wei
    Tsai, Fu-Fei
    Su, Min-I
    Yeh, Hung-I
    Chiang, Yi-Ting
    Hsieh, Chi-Feng
    Chen, Chun-Yen
    ACTA CARDIOLOGICA SINICA, 2019, 35 (04) : 402 - 411
  • [2] Effects of Clopidogrel and proton pump inhibitors on cardiovascular events in patients with type 2 diabetes mellitus after bare metal stent implantation: a nationwide cohort study
    Chen, C. Y.
    Hsieh, C. F.
    Yeh, H. I.
    EUROPEAN HEART JOURNAL, 2017, 38 : 879 - 880
  • [3] Effects of Clopidogrel and Proton Pump Inhibitors on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus After Drug-Eluting Stent Implantation: A Nationwide Cohort Study
    Hsieh, Chi-Feng
    Huang, Weng-Foung
    Chiang, Yi-Ting
    Chen, Chun-Yen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 6 - 6
  • [4] Effects of Clopidogrel and Proton Pump Inhibitors on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus after Drug-Eluting Stent Implantation: A Nationwide Cohort Study
    Hsieh, Chi-Feng
    Huang, Weng-Foung
    Chiang, Yi-Ting
    Chen, Chun-Yen
    PLOS ONE, 2015, 10 (08):
  • [5] Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel
    Kwok, C. S.
    Loke, Y. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (08) : 810 - 823
  • [6] EFFECTS OF THIAZOLIDINEDIONES ON CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS AFTER DRUG-ELUTING STENT IMPLANTATION
    Yeh, S. Z.
    Hsieh, C. F.
    Tsai, Y. W.
    Huang, W. F.
    VALUE IN HEALTH, 2011, 14 (03) : A37 - A37
  • [7] Clinical events in patients undergoing percutaneous coronary intervention with bare-metal stenting after discontinuation of clopidogrel
    Trenk, D.
    Hochholzer, W.
    Valina, C. M.
    Stratz, C.
    Bestehorn, H. -P
    Buettner, H. J.
    Neumann, F-J.
    EUROPEAN HEART JOURNAL, 2010, 31 : 965 - 965
  • [8] Concomitant use of clopidogrel and proton pump inhibitors and major adverse cardiovascular events following coronary stent implantation
    Schmidt, Morten
    Johansen, Martin B.
    Robertson, Douglas J.
    Maeng, Michael
    Kaltoft, Anne
    Jensen, Lisette O.
    Tilsted, Hans-Henrik
    Botker, Hans Erik
    Sorensen, Henrik Toft
    Baron, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B18 - B18
  • [9] Proton Pump Inhibitors Diminish Effectiveness of Clopidogrel after Coronary Stenting in Patients with Diabetes
    Stanek, Eric J.
    Aubert, Ronald E.
    Kreutz, Rolf P.
    Yao, Jianying
    Flockhart, David A.
    Epstein, Robert S.
    DIABETES, 2009, 58 : A273 - A273
  • [10] Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation
    Schmidt, M.
    Johansen, M. B.
    Robertson, D. J.
    Maeng, M.
    Kaltoft, A.
    Jensen, L. O.
    Tilsted, H. -H.
    Botker, H. E.
    Sorensen, H. T.
    Baron, J. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (01) : 165 - 174
12345